CDKN2A and astrocytoma (excluding glioblastoma): Loss of p16 expression is a common occurrence in melanoma and interestingly loss of p16 also correlates strongly with reduced senescence, increased cell division, and progression of PAs into WHO grade II astrocytomas [22,32].